| Accession Number | 0001193125-26-276615 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 22, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | American depositary share | โ | Jun 18, 2026 | Sale | 96 | $143.90 | $13,814.40 | 24,904 | Indirect | By Bioptima Ltd. | View Details | |
Chief Medical Officer | American depositary share | โ | Jun 18, 2026 | Sale | 3,748 | $144.66 | $542,192.05 | 21,156 | Indirect | By Bioptima Ltd. | View Details | |
Chief Medical Officer | American depositary share | โ | Jun 18, 2026 | Sale | 4,861 | $145.43 | $706,958.56 | 16,295 | Indirect | By Bioptima Ltd. | View Details | |
Chief Medical Officer | American depositary share | โ | Jun 18, 2026 | Sale | 1,199 | $146.24 | $175,347.64 | 15,096 | Indirect | By Bioptima Ltd. | View Details | |
Chief Medical Officer | American depositary share | โ | Jun 18, 2026 | Sale | 96 | $147.11 | $14,122.56 | 15,000 | Indirect | By Bioptima Ltd. | View Details |